Intercept Pharmaceuticals, Inc.
NASDAQ:ICPT
19 (USD) • At close November 7, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Intercept Pharmaceuticals, Inc. |
Symbool | ICPT |
Munteenheid | USD |
Prijs | 19 |
Beurswaarde | 794,694,000 |
Dividendpercentage | 0% |
52-weken bereik | 8.82 - 21.86 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jerome B. Durso |
Website | https://www.interceptpharma.com |
An error occurred while fetching data.
Over Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)